cells

2018 round is now closed for new applications

 This call was for bold, innovative research that has the real potential to impact the way prostate cancer is diagnosed, treated or even prevented. 

All proposals must align with our research strategy and must clearly demonstrate the innovative nature of the research and how it will lead to improved health and well-being of men affected by, or at high risk of, prostate cancer. The application process and assessment reflect our increased focus on innovativeness and potential impact.

 

Application & Assessment Process

The application process consists of two stages:

1: Expression of Interest (EOI) Stage

  • The round will close for application at 12pm (noon) Monday 17 September 2018.
  • Applications are firstly validated by the Research Team at Prostate Cancer UK to eliminate those which do not meet the basic eligibility criteria for this call.
  • The remaining applications will then be considered by our Research Advisory Committee, who shall decide which proposals should be shortlisted to the Second Stage.

2: Second Stage (for shortlisted applicants)

  • Shortlisted applicants will be issued with a Second Stage application form the week commencing 12 November 2018.
  • Second Stage applications will need to be submitted by 12pm (noon) on Monday 14 January 2019.
  • Applications will be peer reviewed by at least three independent referees (in accordance with AMRC guidelines).
  • Applicants may then respond to the anonymised referees’ comments the week commencing 4 March 2019.
  • Proposals are further reviewed by our lay assessors and our Research Advisory Committee.

Once the final funding decisions have been confirmed, applicants will be informed of the outcome by email the week commencing May 2019.

All awards made will be in line with our terms and conditions (please note - these terms may be subject to change). 

2018 RIA Stage 2 Guidance Notes